NF-κB, the first quarter-century: remarkable progress and outstanding questions - Test2 - elhamkhani - TriplyDB

NF-κB, the first quarter-century: remarkable progress and outstanding questions

NF-κB, the first quarter-century: remarkable progress and outstanding questions

http://www.wikidata.org/entity/Q26822516

about

Immunoproteasome deficiency modifies the alternative pathway of NFκB signaling Atypical IκB proteins - nuclear modulators of NF-κB signaling Expression of the autoimmune regulator gene and its relevance to the mechanisms of central and peripheral tolerance The CLRX.1/NOD24 (NLRP2P) pseudogene codes a functional negative regulator of NF-κB, pyrin-only protein 4 USP10 inhibits genotoxic NF-κB activation by MCPIP1-facilitated deubiquitination of NEMO Ribosomal protein S3 interacts with the NF-κB inhibitor IκBα Salsalate, an old, inexpensive drug with potential new indications: a review of the evidence from 3 recent studies Human MicroRNA miR-532-5p Exhibits Antiviral Activity against West Nile Virus via Suppression of Host Genes SESTD1 and TAB3 Required for Virus Replication Dietary phytochemicals and neuro-inflammaging: from mechanistic insights to translational challenges The Ubiquitination of NF-κB Subunits in the Control of Transcription Regulation of the Adaptive Immune Response by the IκB Family Protein Bcl-3 The Regulation of NF-κB Subunits by Phosphorylation Induction of CD4(+) Regulatory and Polarized Effector/helper T Cells by Dendritic Cells Shigella IpaH Family Effectors as a Versatile Model for Studying Pathogenic Bacteria Innate Immune Response in Brain, NF-Kappa B Signaling and Cystatins NF-KappaB in Long-Term Memory and Structural Plasticity in the Adult Mammalian Brain Regulation of Met1-linked polyubiquitin signalling by the deubiquitinase OTULIN Chromatin Remodeling and Transcriptional Control in Innate Immunity: Emergence of Akirin2 as a Novel Player The immunogenetics of primary biliary cirrhosis: A comprehensive review When ubiquitin meets NF-κB: a trove for anti-cancer drug development Preparing the first responders: building the inflammatory transcriptome from the ground up FOXO transcription factors throughout T cell biology Regulation of nuclear factor-κB in autoimmunity Role of disorder in IκB-NFκB interaction Aberrant nuclear factor-kappa B activity in acute myeloid leukemia: from molecular pathogenesis to therapeutic target The structure, function and evolution of proteins that bind DNA and RNA NF-κB in inflammation and renal diseases Cytokines from the pig conceptus: roles in conceptus development in pigs Specific recognition of linear polyubiquitin by A20 zinc finger 7 is involved in NF-κB regulation Structure of an SspH1-PKN1 Complex Reveals the Basis for Host Substrate Recognition and Mechanism of Activation for a Bacterial E3 Ubiquitin Ligase The adaptor protein CIN85 assembles intracellular signaling clusters for B cell activation Molecular basis for specificity of the Met1-linked polyubiquitin signal Modulation of the host innate immune and inflammatory response by translocated bacterial proteins TCR signaling to NF-κB and mTORC1: Expanding roles of the CARMA1 complex SP-R210 (Myo18A) Isoforms as Intrinsic Modulators of Macrophage Priming and Activation Negative Regulation of CARD11 Signaling and Lymphoma Cell Survival by the E3 Ubiquitin Ligase RNF181 TRAF Family Member-associated NF-κB Activator (TANK) Inhibits Genotoxic Nuclear Factor κB Activation by Facilitating Deubiquitinase USP10-dependent Deubiquitination of TRAF6 Ligase The mechanisms behind the therapeutic activity of BET bromodomain inhibition Anti-inflammatory effects of epoxyeicosatrienoic acids Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment

P2860

Q21133685-2688A50C-6C8D-4D71-8D4E-C6CE94C4C182 Q21245512-01FFC2CA-04AC-437B-B8A1-30D92B4419DB Q21296698-18FD9602-AFED-4A25-A307-30969B13B27C Q24298464-B0A17E1C-841A-4F1F-A3C3-0570C951A714 Q24309553-B36CB923-63D3-41F4-BDAA-FD35DB281BD6 Q24322643-5465548E-C4E5-4AA0-AAFE-9633D5AB4891 Q24562012-F67CEC57-8375-44D1-A4A7-89005DA06A28 Q26700089-BA50A7E2-6B7C-4A8E-954F-A0F31CB911D5 Q26747783-EC463820-1A03-4CE1-BE2E-5EA538CC336E Q26748938-63EDE78C-2105-4EF6-AA2E-F73CAD6DB3A7 Q26749588-4D0C9DDE-3607-41DA-8005-34F0D4C39E8E Q26752951-B46B001E-349B-477C-BDF8-D8F3E62E847E Q26764866-D63DE798-7532-4848-82E6-FD2FBB75833E Q26771364-8BE78BB7-1950-4922-A6CA-9D372431ACD7 Q26773162-868C913D-0A8B-4E75-84F8-00C2A074814A Q26774833-065CE3D6-B9D2-4A99-BC87-07F6F53DCF2B Q26778774-395C65F8-96EB-497B-86FA-C62CB4DD03E9 Q26796578-D049DD40-42F3-4440-901A-58130521EC12 Q26801377-9011E97C-6037-4A5E-B388-BB7C4F1B9059 Q26827754-87AAE670-E2EE-473F-A025-1CA254C9F2CA Q26849425-A31C29FD-B6B0-4EB8-ACFB-C238A74DC693 Q26853741-BC2C7A0E-19E0-457F-837A-A36F5E03F30C Q26860148-747698D0-37F7-46CE-AB85-8885375D7019 Q26865182-B77585AF-3B1A-4979-9557-5773843A6A06 Q26995561-211A330C-8BFA-4064-8D61-AB6BA4CC24E2 Q27003938-6FC01469-FE61-4925-A04A-B92C2A79974B Q27021276-B30BC947-3CD4-4E2F-99DA-5A63E6E9725F Q27027827-6F629195-FC27-49F3-8DAB-D0FAE7CC90A1 Q27674024-2EA1794E-6540-4F10-B95F-41F527392779 Q27680640-956F8141-9A79-4878-83DE-8925DD9B039B Q27714533-4752CE11-5C4E-4045-B15D-2635408250E6 Q28072740-7100C466-C1FD-43D0-8FDF-D9F3E20DAFCF Q28083042-87083AC5-4334-4B41-B333-93A6DEF191AD Q28085394-33AC5449-48AE-4D08-ACEF-0A4ADCEBB511 Q28116165-A48914D7-8E2C-4AC5-819C-DD3AD512849B Q28117437-0E14AF9D-ADB6-4291-BAEE-DA51F4A977A7 Q28118631-51DC60EB-148B-4539-AE4A-B644CFB71B0A Q28241504-21522081-E50D-46FA-B61D-CB819E9A211C Q28272187-FE8FEA2A-8CD9-4CE1-BE94-C8C9E6293F58 Q28296759-19FD6B68-5560-4B20-B3EB-B42C87E0E167

P2860

NF-κB, the first quarter-century: remarkable progress and outstanding questions

http://www.wikidata.org/entity/Q26822516

description

2012 nî lūn-bûn

@nan

2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

NF-κB, the first quarter-century: remarkable progress and outstanding questions

@ast

NF-κB, the first quarter-century: remarkable progress and outstanding questions

@en

NF-κB, the first quarter-century: remarkable progress and outstanding questions

@nl

type

label

NF-κB, the first quarter-century: remarkable progress and outstanding questions

@ast

NF-κB, the first quarter-century: remarkable progress and outstanding questions

@en

NF-κB, the first quarter-century: remarkable progress and outstanding questions

@nl

prefLabel

NF-κB, the first quarter-century: remarkable progress and outstanding questions

@ast

NF-κB, the first quarter-century: remarkable progress and outstanding questions

@en

NF-κB, the first quarter-century: remarkable progress and outstanding questions

@nl

P1433

Q26822516-98EBB5B0-BC6D-40BB-935C-583D76C8DFA8

P1476

Q26822516-EFDD9FEB-89C0-4A8B-B941-15CFB6E4B69B

P2093

Q26822516-E26D44DD-A943-44E8-82A0-B2FF1385388A

P2860

Q26822516-010A0218-7A82-441F-9BC8-D6EBCFCDD0EC

Q26822516-035174C1-BEB3-4393-8AA4-7E2864C7A683

Q26822516-0355FBFF-9A4D-49AE-A4D6-FDFBCD6F080A

Q26822516-0375897B-EC3E-4743-8C37-5BF205AA6CC8

Q26822516-03AF5976-8D63-4469-85AF-E48ABFA5867C

Q26822516-03B3E9E5-3C7B-4A6C-A73D-515574D106B9

Q26822516-040B2D74-0EAF-4E71-958D-93F5F11405B3

Q26822516-04879010-96E0-4990-9874-3407F093DCD3

Q26822516-059C4DE9-98EA-492D-8AE5-3880A31BBC01

Q26822516-05D88E97-A632-4440-A4E3-7CCCB0187E9D

P304

Q26822516-5226C2B1-C19A-4F16-BC3F-F6DC29409265

P31

Q26822516-B1777F33-BBD5-4445-83C3-A5A68B6BC2FB

P3181

Q26822516-7D6E4839-AB22-4E90-84C2-97641EA40A9B

P356

Q26822516-B12FE779-C093-47EC-AAFB-64FAABBCCAF2

P407

Q26822516-33FFBC00-38E3-40C8-8D0F-727C9BC83C8C

P433

Q26822516-A0D71E82-6310-483C-ABA3-30E80E91E2FA

P478

Q26822516-6A6CFBC5-3FB3-48C9-B349-5AB889CC0AB1

P50

Q26822516-8CD0FBFF-7329-4D66-97F8-A45917FE6A6A

P577

Q26822516-DABCCAED-C429-439E-B9F2-41D9A474E734

P5875

Q26822516-4ED4838E-8E12-4917-AAE6-1231E64ECEF2

P698

Q26822516-352B5580-1DFB-4413-8D5F-1BF39A4B812A

P921

Q26822516-3D8B46F2-1D32-4254-8E99-483596C6DBFA

P932

Q26822516-031CCDE2-D61D-4D50-94AA-57871560ABA3

P3181

P356

P1433

Genes & Development

P1476

NF-κB, the first quarter-century: remarkable progress and outstanding questions

@en

P2093

Sankar Ghosh

http://www.w3.org/2001/XMLSchema#string

P2860

Signal-induced ubiquitination of IkappaBalpha by the F-box protein Slimb/beta-TrCP

A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway

Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction

Identification of the receptor component of the IkappaBalpha-ubiquitin ligase

Identification of a cell protein (FIP-3) as a modulator of NF-kappaB activity and as a target of an adenovirus inhibitor of tumor necrosis factor alpha-induced apoptosis

Physical interaction of the bHLH LYL1 protein and NF-kappaB1 p105

Functional isoforms of IkappaB kinase alpha (IKKalpha) lacking leucine zipper and helix-loop-helix domains reveal that IKKalpha and IKKbeta have different activation requirements

vCLAP, a caspase-recruitment domain-containing protein of equine Herpesvirus-2, persistently activates the Ikappa B kinases through oligomerization of IKKgamma

NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100

NF-kappa B-inducible BCL-3 expression is an autoregulatory loop controlling nuclear p50/NF-kappa B1 residence

P304

203-234

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

393434

http://www.w3.org/2001/XMLSchema#string

P356

10.1101/GAD.183434.111

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P50

Matthew S Hayden

P577

2012-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221803655

http://www.w3.org/2001/XMLSchema#string

P698

22302935

http://www.w3.org/2001/XMLSchema#string

P921

P932

3278889

http://www.w3.org/2001/XMLSchema#string